Latest Articles
Supreme Court seems ready to uphold ban on gender-affirming care for minors - KDLG
Supreme Court seems ready to uphold ban on gender-affirming care for minors KDLG
Published: Dec. 4, 2024, 6:25 p.m.
Supreme Court hears challenge to law banning gender-affirming care for trans kids - KCBX
Supreme Court hears challenge to law banning gender-affirming care for trans kids KCBX
Published: Dec. 4, 2024, 10 a.m.
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update …
Published: Dec. 4, 2024, 8:10 a.m.
Amy Schumer Addresses Comments on Her 'Puffier' Face and Provides Health Update - AOL
Amy Schumer Addresses Comments on Her 'Puffier' Face and Provides Health Update AOL
Published: Dec. 4, 2024, 6:49 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News StockTitan
Published: Dec. 4, 2024, 12:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News StockTitan
Published: Dec. 4, 2024, midnight
Free Press report: former egg donors share hidden risks of giving away genetics - CatholicVote org
Free Press report: former egg donors share hidden risks of giving away genetics CatholicVote org
Published: Dec. 3, 2024, 9:51 p.m.
New research links depression to more painful periods - Fast Company
New research links depression to more painful periods Fast Company
Published: Dec. 3, 2024, 9:02 p.m.
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer OncLive
Published: Dec. 3, 2024, 5:11 p.m.
Condition affecting millions linked with premature death and cancer risks - Express
Condition affecting millions linked with premature death and cancer risks Express
Published: Dec. 3, 2024, 12:58 p.m.
Link copied to clipboard!